Vital Signs The Analyst's Perspective - April 2016 Issue

Vital Signs The Analyst's Perspective - April 2016 Issue

RELEASE DATE
24-May-2016
REGION
Global
Research Code: 9A35-00-4B-00-00
SKU: HC02640-GL-MR_18576
$450.00
In stock
SKU
HC02640-GL-MR_18576
$450.00
Links

Pay by invoice

ENQUIRE NOW

Description

This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.

Table of Contents

Related Research

Growth Insights—Real World Evidence Analytics Solutions Market

Release Date: 24-Apr-18
Region: North America

Global Biologics Market—Companies-to-Action

Release Date: 20-Nov-17
Region: North America

East African Pharmaceutical Market, Forecast to 2021

Release Date: 27-Sep-17
Region: Africa

Global CRO Market, Forecast to 2021

Release Date: 19-Apr-17
Region: Asia Pacific

Biomarkers Enabling Diabetes and Obesity Management

Release Date: 02-Mar-17
Region: Global

2016 Indonesia Transformational Health Insights

Release Date: 31-May-2016
Region: Asia Pacific

Pharmaceutical Market Access Strategy for Ethiopia

Release Date: 27-May-2016
Region: Africa
This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.
More Information
No Index No
Podcast No
Author Christi Bird
Industries Healthcare
WIP Number 9A35-00-4B-00-00
Is Prebook No